CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1996 Publications

11-17

 

1. Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.
Schwartz BF, Auman R, Peretsman SJ, Moul JW, Deshon GE, Hernandez J, Rozanski TA, Thrasher JB:
J. Surg. Oncol, 61:131-133, 1996.

 

2. Protein expression of p53, bcl-2 and Ki-67 (MIBI) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
Moul, JW, Bettencourt, MC, Sesterhenn, IA, Mostofi, FK, McLeod, DG, Srivastava, S, and Bauer, JJ:
Surgery, 120:159-167, 1996.

 

3. Management of Prostate Cancer for Primary Care: Epidemiology and Screening.
Moul JW:
Fed Prac (Supplement) 1996, pp 3-8.

 

4. Cathepsin-D and Epidermal Growth Factor Receptor (EGFR), immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.
Moul JW, MayGarden SJ, Ware JL, Mohler JL, Maher PD, Schenkman NS, and Ho CK:
J Urol, 155:982-985, 1996.

 

5. Prognostic factors in low-stage non-seminomatous testicular cancer.
Moul JW, Heidenreich A:
Oncology, 10 (9): 1359-1374, 1996.

 

6. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal-access health care system.
Moul JW, Douglas TH, McCarthy WF, and McLeod DG:
J Urol 155:1667-1673, 1996.

 

7. Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA.
Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW:
Urology, 48(Suppl.) S76, 1996.

 

8. Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA.
Morgan TO, McLeod DG, Leifer ES, Moul JW, Murphy GP:
The Prostate (Suppl. 7):58-63, 1996.

 

9. Age-specific reference ranges for prostate specific antigen-based detection of prostate cancer in African American men.
Morgan TO, Jacobsen SJ, McCarthy WF, McLeod DG and Moul JW:
New England Journal of Medicine, 335:304-310, 1996.

 

10. Renal milk of calcium: contraindication to extracorporeal shock wave lithotripsy.
Heidenreich A, Vorreuther R, Krug B, Moul JW, Engelmann UH.
Techniques in Urology, 2:121-125, 1996.